Fabio
93 lines
5.3 KiB
Markdown
93 lines
5.3 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Pharmaceutical Substance Manufacturing Grant Fund; created."
|
||
description: "Pharmaceutical Substance Manufacturing Grant Fund. Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. This bill is identical to HB 1076."
|
||
jurisdiction: "us/states/va"
|
||
legislature: "Virginia General Assembly"
|
||
session: "2026"
|
||
identifier: "SB 527"
|
||
citation: "Virginia SB 527 (2026)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["R. Creigh Deeds"]
|
||
version_count: 2
|
||
action_count: 29
|
||
vote_count: 7
|
||
first_action: "2026-01-13"
|
||
last_action: "2026-04-13"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/c63c0e97-1fbb-41f4-97ed-249c9c1d2463"
|
||
source_url: "https://lis.virginia.gov/bill-details/20261/SB527"
|
||
source_hash: "b582fb3c7da6cb68fd809a4f4538ea57e23194c070858670aa82f24ea2ef7ef9"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-va"]
|
||
---
|
||
|
||
# Virginia SB 527 (2026) — Pharmaceutical Substance Manufacturing Grant Fund; created.
|
||
|
||
Pharmaceutical Substance Manufacturing Grant Fund. Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. This bill is identical to HB 1076.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Introduced** (filed) — [source](https://lis.blob.core.windows.net/files/1090696.PDF)
|
||
2. **Enrolled** (enrolled) — [source](https://lis.blob.core.windows.net/files/1191594.PDF)
|
||
|
||
## Votes
|
||
|
||
- Reported from Appropriations — **22–0** (pass) · lower
|
||
- Reported from Finance and Appropriations — **14–0** (pass) · upper
|
||
- Constitutional reading dispensed R — **40–0** (pass) · upper
|
||
- Rereferred from Commerce and Labor — **11–0** (pass) · upper
|
||
- Passage R — **39–0** (pass) · upper
|
||
- Rereferred from Education and Health — **14–0** (pass) · upper
|
||
- H VOTE: — **92–6** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- R. Creigh Deeds — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2026-01-13** Prefiled and ordered printed; Offered 01-14-2026 26102905D `filing, introduction`
|
||
- **2026-01-13** Referred to Committee on Education and Health `referral-committee`
|
||
- **2026-01-22** Rereferred from Education and Health to Commerce and Labor (14-Y 0-N) `referral-committee`
|
||
- **2026-01-23** Fiscal Impact Statement from Department of Planning and Budget (SB527)
|
||
- **2026-02-02** Rereferred from Commerce and Labor to Finance and Appropriations (11-Y 0-N) `referral-committee`
|
||
- **2026-02-10** Reported from Finance and Appropriations (14-Y 0-N) `committee-passage`
|
||
- **2026-02-11** Rules suspended
|
||
- **2026-02-11** Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
|
||
- **2026-02-11** Passed by for the day Block Vote (Voice Vote)
|
||
- **2026-02-12** Read second time `reading-2`
|
||
- **2026-02-12** Engrossed by Senate (Voice Vote)
|
||
- **2026-02-13** Read third time and passed Senate (39-Y 0-N 0-A) `passage, reading-3`
|
||
- **2026-02-19** Placed on Calendar
|
||
- **2026-02-19** Read first time `reading-1`
|
||
- **2026-02-19** Referred to Committee on Appropriations `referral-committee`
|
||
- **2026-02-19** Assigned HAPP sub: Commerce Agriculture & Natural Resources `referral-committee`
|
||
- **2026-02-25** Reported from Appropriations (22-Y 0-N) `committee-passage`
|
||
- **2026-02-27** Read second time `reading-2`
|
||
- **2026-03-02** Moved from Uncontested Calendar to Regular Calendar
|
||
- **2026-03-02** Read third time `reading-3`
|
||
- **2026-03-02** Passed House (92-Y 6-N 0-A) `passage`
|
||
- **2026-03-05** Enrolled `enrolled`
|
||
- **2026-03-05** Bill text as passed Senate and House (SB527ER) `passage`
|
||
- **2026-03-05** Fiscal Impact Statement from Department of Planning and Budget (SB527)
|
||
- **2026-03-05** Signed by Speaker `passage`
|
||
- **2026-03-05** Signed by President `passage`
|
||
- **2026-03-10** Enrolled Bill communicated to Governor on March 10, 2026 `enrolled, executive-receipt`
|
||
- **2026-03-10** Governor's Action Deadline 11:59 p.m., April 13, 2026 `executive-receipt`
|
||
- **2026-04-13** Approved by Governor-Chapter 809 (effective 7/1/2026) `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/c63c0e97-1fbb-41f4-97ed-249c9c1d2463`. Confidence: reported (aggregated from official Virginia legislature records).
|
||
|